Sort
261,768 grants matching “gene therapy”
Genetic Determinants of Antidepressant Response in the STAR*D Cohort
$1,009,301Francis J McMahon · National Institute Of Mental Health · ZIA · FY2009 · MH
molecular mechanisms of the blood brain barrier function and regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2022 · NS
Molecular Mechanisms of the Blood Brain Barrier Function and Regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2025 · NS
Molecular Mechanisms of the Blood Brain Barrier Function and Regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2023 · NS
molecular mechanisms of the blood brain barrier function and regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2020 · NS
molecular mechanisms of the blood brain barrier function and regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2021 · NS
A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomy
$1,009,285Tere M. Williams · Dub Therapeutics Inc. · R44 · FY2025 · EY
Nuclear Factor-kappaB in Ovarian Cancer
$1,009,250Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
$1,009,228Michael T Barrett · Binary Genomics, Inc. · R44 · FY2025 · CA
Project 3: Developmental trajectories in infants at genetic risk for autism
$1,009,214Dima Amso · Columbia University Health Sciences · P50 · FY2024 · HD
A novel gene therapy approach to reduce neurotoxicity in Parkinson's disease
$1,009,212Lena Cecilia Brundin · Van Andel Research Institute · R61 · FY2025 · NS
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$1,009,129Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
$1,009,106Martin Carroll · University Of Pennsylvania · U54 · FY2024 · CA
Technology to Select Candidates for Prophylactic Treatments to Prevent Sporadic Breast Cancers
$1,009,044Indira None Poola · Silbiotech, Inc. · R44 · FY2016 · CA
Autoimmunity: Mechanisms of Unresponsiveness
$1,009,020Charles Garrison Fathman · Stanford University · P01 · FY2008 · AI
An integrated computational and functional genomics discovery engine for preclini
$1,009,007Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,008,900David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Synergistic role of signaling and epigenetics in leukemic transformation
$1,008,900Ross L Levine · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Novel therapeutic development for small cell lung cancer
$1,008,900Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Towards targeting the lymphoma microenvironment
$1,008,898Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Development of synthetic sphingolipids for prostate cancer therapy
$1,008,833Daniel Gil · Siege Pharmaceuticals, Inc. · R44 · FY2020 · CA
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,008,827Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Cerebral Structural And Metabolic Correlates Of Aggressive Or Addictive Behavior
$1,008,738Daniel W Hommer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA